FDA OKs Bracco's CardioGen-82 infusion system

By AuntMinnie.com staff writers

October 16, 2020 -- The U.S. Food and Drug Administration (FDA) has cleared Bracco Diagnostics' new CardioGen-82 infusion system for cardiac PET myocardial perfusion imaging (MPI). The new infusion system model will replace Bracco's current infusion system.

CardioGen-82 is a closed system used to produce rubidium-82 chloride injection for intravenous administration. The new version has ergonomic details that provide access to all system components while minimizing radiation exposure for staff and patients, Bracco said.

In addition, the new generation has smart features like dosing options and other protocol parameters that improve workflow and eliminate manual record-keeping.

Copyright © 2020 AuntMinnie.com

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking